Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Share-based Compensation (2016 - 2026)

iBio has reported Share-based Compensation over the past 17 years, most recently at $377000.0 for Q1 2026.

  • Quarterly Share-based Compensation rose 1.89% to $377000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, down 21.45% year-over-year, with the annual reading at $1.5 million for FY2025, 22.53% down from the prior year.
  • Share-based Compensation was $377000.0 for Q1 2026 at iBio, up from $253000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $2.0 million in Q2 2023 and troughed at $253000.0 in Q4 2025.
  • The 5-year median for Share-based Compensation is $454000.0 (2023), against an average of $636294.1.
  • Year-over-year, Share-based Compensation skyrocketed 224.33% in 2022 and then crashed 84.89% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $915000.0 in 2022, then crashed by 50.38% to $454000.0 in 2023, then rose by 4.63% to $475000.0 in 2024, then tumbled by 46.74% to $253000.0 in 2025, then skyrocketed by 49.01% to $377000.0 in 2026.
  • Per Business Quant, the three most recent readings for IBIO's Share-based Compensation are $377000.0 (Q1 2026), $253000.0 (Q4 2025), and $323000.0 (Q3 2025).